Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04111874 · ClinicalTrials.gov registry record · NA

Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD

A NA study, sponsored by Baylor College of Medicine.

Completed
Registry status
NA
Development phase
87
Enrollment target

NCT04111874: Completed NA study, sponsored by Baylor College of Medicine.

NCT04111874 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04111874, a NA study, has completed, sponsored by Baylor College of Medicine.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target

Study Summary

This study implements an anxiety-focused, parent-led, therapist-assisted cognitive behavioral teletherapy for parents of youth with ASD and anxiety.

Primary Outcome

Clinician rated child anxiety severity throughout the past week. Each item is scored on a 0 to 5 scale (higher scores correspond to greater severity), yielding a total between 0 and 30.

Interventions

  • BEHAVIORAL Cognitive Behavioral Teletherapy LTA
  • BEHAVIORAL Cognitive Behavioral Teletherapy STA

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2019-07-30
Est. Completion 2023-12-31
Phase NA
Baylor College of Medicine

616 total trials

What the finished NCT04111874 record still lists

NCT04111874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Teletherapy LTA is the first listed.

NCT04111874 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04111874 about?

NCT04111874 is a clinical study titled "Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD". This study implements an anxiety-focused, parent-led, therapist-assisted cognitive behavioral teletherapy for parents of youth with ASD and anxiety.

What is the current status of trial NCT04111874?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2019-07-30. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT04111874?

The interventions under investigation include: Cognitive Behavioral Teletherapy LTA (BEHAVIORAL), Cognitive Behavioral Teletherapy STA (BEHAVIORAL).

Who is sponsoring clinical trial NCT04111874?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04111874's enrollment target sits among peer trials

87 974th of 2000 higher than 1,025 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03292601 · 87 participants · NA

    Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)

  • NCT04291105 · 87 participants · Phase 2

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

  • NCT04565795 · 87 participants · NA

    Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

  • NCT05607004 · 87 participants · Phase 2

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04111874, the US trial registry maintained by the National Library of Medicine. NCT04111874 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.